ArticleScientific reports2025
Oral mucosal lesions in Polish patients with acute myeloid leukemia after allogeneic hematopoietic cell transplantation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The number of allogeneic hematopoietic cell transplantation constantly increases. Therefore, there is an urgent need to carefully analyze the general and oral health state of people with acute myeloid leukemia who underwent this procedure. This study aimed to investigate the type and frequency of oral mucosal lesions in patients with acute myeloid leukemia after allogeneic hematopoietic cell transplantation, depending on the intensity of the conditioning regimen. Eighty patients diagnosed with acute myeloid leukemia were assigned to two groups based on the conditioning used before transplantation. The dental team investigated the oral mucosa in all patients thrice during the treatment. The most common oral pathological lesion in the study group was mucositis, which developed in a significantly higher percentage of patients who underwent myeloablation therapy compared to reduced intensity conditioning (p = 0.0335). Other frequently found eruptions included massive coating on the dorsal tongue surface, petechiae, and exfoliating cheilitis. The type of conditioning did not significantly influence their frequency. A significant increase in post-transplant lesions was observed on the lips, sublingual area, and floor of the mouth. There were no statistically significant differences in the site of lesions depending on the type of conditioning. Oral mucosal pathological changes in the study group were frequent. The type of conditioning influenced the frequency of mucositis but did not affect the frequency and the location of other types of oral mucosal lesions. Providing the patients qualified for chemotherapy with professional dental support is important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.